A novel molecule ZYZ329 targeting histone methyltransferase SMYD3 suppresses pathological angiogenesis via the driven mitochondrial ROS/HIF-1α/VEGFA axis
Abstract Background The histone methyltransferase SMYD3 (SET and MYND domain containing 3) is critical for vascular homeostasis and may be implicated in pathological angiogenesis. However, its mechanism remains elusive, and targeted inhibitors are in early-stage development. We aim to clarify whethe...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2026-02-01
|
| coleção: | Journal of Translational Medicine |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12967-025-07580-2 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
